Navigation path

Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

Pegylated recombinant human interleukin-10

EU orphan designation number: EU/3/16/1804   
Active ingredient: Pegylated recombinant human interleukin-10
Indication: Treatment of pancreatic cancer
Sponsor: Eli Lilly Nederland B.V.
Papendorpseweg 83, 3528 BJ Utrecht, Nederland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
15/12/2016 Orphan designation EMA/OD/193/16 (2016)8704 of 12/12/2016
23/10/2018 Transfer of orphan designation (2018)6994 of 18/10/2018